FDA GDUFA Testimony Presentation Slides

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-03-02-2016
Volume 40
Issue 3

Slides from the FDA GDUFA presentation before the Senate Health, Education, Labor and Pensions Committee in January 2016.

Slides from the FDA GDUFA presentation before the Senate Health, Education, Labor and Pensions Committee in January 2016.

External Link - GDUFATestimony_presentationslides.pdf

Articles in this issue
Gaining Insight from Process Control Data
Gaining Insight from Process Control Data
PT0316_Troubleshooting_495forweb.gif
Designing a Biomanufacturing Facility Incorporating Single-Use Technologies
Generic-Drug Production and Oversight Challenge FDA and Manufacturers
Phase-Appropriate GMP
How Important is Data Integrity to Regulatory Bodies?
How Important is Data Integrity to Regulatory Bodies?
FDA GDUFA Testimony Presentation Slides
Keynote Series Addresses Crucial Industry Issues
Polymorph Screening for Identification of Relevant Crystalline Forms
Polymorph Screening for Identification of Relevant Crystalline Forms
Building Consensus for E&L Testing Standards
Building Consensus for E&L Testing Standards
Tecan_225.jpg
Multimode Microplate Reader Improves Sensitivity
Thermo_225.jpg
High-Pressure Ion Chromatography System
Zeiss_225.jpg
Confocal Microscope for Surface Analysis
Pharma Outsourcing Market Expands
Redefining Pharma Agility
Redefining Pharma Agility
Tackling Regulatory Challenges of EU’s Variations Framework
Recent Videos
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Behind the Headlines, Episode 18
Related Content
Old rusty shovel in the ground on the building | Image Credit: © photolink - stock.adobe.com

Piramal Pharma Holds Groundbreaking at Kentucky Facility, Part of $90 Million Investment Plan

Patrick Lavery
July 2nd 2025
Article

The expansion of the Kentucky site accounts for $80 million of the announced investment, with the remaining money earmarked for facilities in Michigan.

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Patrick Lavery
May 30th 2025
Podcast

In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.

NÜRNBERG / GERMANY - APRIL 7, 2019: Siemens Logo on an office building in Nürnberg. Siemens is a German engineering company | Image Credit: © filmbildfabrik - stock.adobe.com

Siemens Finalizes $5.1B Dotmatics Acquisition

Christopher Cole
July 1st 2025
Article

Siemens expands AI-driven pharma software portfolio, integrating Dotmatics’ platform to connect drug research, development, and manufacturing digitally.

Site Logo

Transformations in Drug Development for Cell and Gene Therapies

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Hikma Pharmaceuticals Invests $1 Billion to Expand US Generic Drug Capabilities, Releases Sustainability Report

Susan Haigney
June 30th 2025
Article

The company is expanding its US manufacturing and R&D capabilities with a $1 billion investment by 2030.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Aenova Adds Cold Chain Warehouse to Latina, Italy Site

Susan Haigney
June 27th 2025
Article

The new building expands on the company’s supply chain solutions for biologics and temperature-sensitive pharmaceuticals.